Form 4: Repligen Corp Director Karen A. Dawes Executes Stock Option
SEC Form 4 Filing
Karen A. Dawes, a director at Repligen Corp, exercised stock options to acquire 2,953 shares of common stock at $67.71 per share on June 14, 2024.
Summary
- On June 14, 2024, Karen A. Dawes, a director of Repligen Corp, exercised stock options.
- This transaction involved the acquisition of 2,953 shares of Repligen Corp common stock at a price of $67.71 per share.
- Following the transaction, Dawes directly owns 88,170 shares of Repligen Corp common stock.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of a routine transaction. It doesn't inherently indicate positive or negative sentiment.
Industry Context
Form 4 filings are standard disclosures required by the SEC when insiders, such as directors and officers, transact in their company's stock. These filings provide transparency to the market regarding insider activity.
Stakeholder Impact
- The transaction may have a minor impact on shareholders due to the change in ownership, but it is unlikely to be significant.
Key Dates
| Date | Description |
|---|---|
| 06/14/2024 | Date of transaction: Karen A. Dawes exercised stock options and acquired common stock. |
| 05/15/2029 | Expiration date of the stock option. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.